Hong Kong-listed pharmaceutical stocks continued to be strong, with CanSino Biologics (06185.HK) rising more than 10%, Junshi Biosciences (01877.HK) rising more than 9%, and Clover Biopharmaceuticals (02197.HK) and Akeso Biopharmaceuticals (09926.HK) following suit.